722 related articles for article (PubMed ID: 24021859)
1. Contested space in the pharmacy: public attitudes to pharmacy harm reduction services in the West of Scotland.
Gidman W; Coomber R
Res Social Adm Pharm; 2014; 10(3):576-87. PubMed ID: 24021859
[TBL] [Abstract][Full Text] [Related]
2. Community pharmacy harm reduction services for drug misusers: national service delivery and professional attitude development over a decade in Scotland.
Matheson C; Bond CM; Tinelli M
J Public Health (Oxf); 2007 Dec; 29(4):350-7. PubMed ID: 17986490
[TBL] [Abstract][Full Text] [Related]
3. A qualitative exploration of opinions on the community pharmacists' role amongst the general public in Scotland.
Gidman W; Cowley J
Int J Pharm Pract; 2013 Oct; 21(5):288-96. PubMed ID: 23418884
[TBL] [Abstract][Full Text] [Related]
4. Community pharmacies and the provision of opioid substitution services for drug misusers: changes in activity and attitudes of community pharmacists across England 1995-2005.
Sheridan J; Manning V; Ridge G; Mayet S; Strang J
Addiction; 2007 Nov; 102(11):1824-30. PubMed ID: 17935587
[TBL] [Abstract][Full Text] [Related]
5. How to enhance public health service utilization in community pharmacy?: general public and health providers' perspectives.
Saramunee K; Krska J; Mackridge A; Richards J; Suttajit S; Phillips-Howard P
Res Social Adm Pharm; 2014; 10(2):272-84. PubMed ID: 23089293
[TBL] [Abstract][Full Text] [Related]
6. I could take the judgment if you could just provide the service: non-prescription syringe purchase experience at Arizona pharmacies, 2018.
Meyerson BE; Lawrence CA; Cope SD; Levin S; Thomas C; Eldridge LA; Coles HB; Vadiei N; Kennedy A
Harm Reduct J; 2019 Sep; 16(1):57. PubMed ID: 31533730
[TBL] [Abstract][Full Text] [Related]
7. Zoned Out: "NIMBYism", addiction services and municipal governance in British Columbia.
Bernstein SE; Bennett D
Int J Drug Policy; 2013 Nov; 24(6):e61-5. PubMed ID: 23680227
[TBL] [Abstract][Full Text] [Related]
8. Methadone, a contested substance: Danish methadone policy in the 1970s.
Houborg E
Int J Drug Policy; 2013 Nov; 24(6):e73-80. PubMed ID: 24120441
[TBL] [Abstract][Full Text] [Related]
9. The role of policy in community pharmacies' response to injection-drug use: results of a nationwide Canadian survey.
Myers T; Cockerill R; Millson M; Rankin J; Worthington C
AIDS Public Policy J; 1996; 11(2):78-88. PubMed ID: 10915241
[TBL] [Abstract][Full Text] [Related]
10. Community pharmacy services for people with drug problems over two decades in Scotland: Implications for future development.
Matheson C; Thiruvothiyur M; Robertson H; Bond C
Int J Drug Policy; 2016 Jan; 27():105-12. PubMed ID: 26723885
[TBL] [Abstract][Full Text] [Related]
11. Improved treatment-retention for patients receiving methadone dosing within the clinic providing physician and other health services (onsite) versus dosing at community (offsite) pharmacies.
Gauthier G; Eibl JK; Marsh DC
Drug Alcohol Depend; 2018 Oct; 191():1-5. PubMed ID: 30064001
[TBL] [Abstract][Full Text] [Related]
12. Improving health and social care relationships for harm reduction.
Allman D; Myers T; Schellenberg J; Strike C; Cockerill R; Cavalieri W
Int J Drug Policy; 2007 May; 18(3):194-203. PubMed ID: 17689366
[TBL] [Abstract][Full Text] [Related]
13. 'Standing Outside the Junkie Door'-service users' experiences of using community pharmacies to access treatment for opioid dependency.
Radley A; Melville K; Easton P; Williams B; Dillon JF
J Public Health (Oxf); 2017 Dec; 39(4):846-855. PubMed ID: 27915259
[TBL] [Abstract][Full Text] [Related]
14. Views of the Scottish general public on community pharmacy weight management services: international implications.
Weidmann AE; Cunningham S; Gray G; Hansford D; Bermano G; Stewart D
Int J Clin Pharm; 2012 Apr; 34(2):389-97. PubMed ID: 22382887
[TBL] [Abstract][Full Text] [Related]
15. Dealing with aggressive methadone patients in community pharmacy: a critical incident study.
Irwin A; Laing C; Mearns K
Res Social Adm Pharm; 2012; 8(6):542-51. PubMed ID: 22381914
[TBL] [Abstract][Full Text] [Related]
16. Public stigma in health and non-healthcare students: attributions, emotions and willingness to help with adolescent self-harm.
Law GU; Rostill-Brookes H; Goodman D
Int J Nurs Stud; 2009 Jan; 46(1):107-18. PubMed ID: 18962601
[TBL] [Abstract][Full Text] [Related]
17. HIV prevention and drug treatment services for drug misusers: a national study of community pharmacists' attitudes and their involvement in service specific training.
Sheridan J; Strang J; Taylor C; Barber N
Addiction; 1997 Dec; 92(12):1737-48. PubMed ID: 9581006
[TBL] [Abstract][Full Text] [Related]
18. Stigmatizing harm reduction through language: a case study into the use of "addict" and opposition to supervised injection sites in Canada.
Cortina SC
J Addict Nurs; 2013; 24(2):102-7. PubMed ID: 24621488
[TBL] [Abstract][Full Text] [Related]
19. Prescribing and dispensing for drug misusers in primary care: current practice in Scotland.
Matheson C; Bond CM; Hickey F
Fam Pract; 1999 Aug; 16(4):375-9. PubMed ID: 10493708
[TBL] [Abstract][Full Text] [Related]
20. How youth-friendly are pharmacies in New Zealand? Surveying aspects of accessibility and the pharmacy environment using a youth participatory approach.
Horsfield E; Kelly F; Clark T; Sheridan J
Res Social Adm Pharm; 2014; 10(3):529-38. PubMed ID: 23981912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
